Esophageal carcinoma
Showing 1 - 25 of >10,000
Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)
Not yet recruiting
- Esophageal Carcinoma
- Immune Checkpoint Inhibitors
- (no location specified)
Jul 6, 2023
Endoscopic Submucosal Dissection Versus Esophagectomy for Early
Completed
- Esophageal Cancer
- Endoscopic submucosal dissection
- Esophagectomy
-
Shanghai, ChinaChanghai Hospital, Naval Medical University
Sep 27, 2023
Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)
Not yet recruiting
- Esophageal Carcinoma
- Neoadjuvant Therapy
- Toripalimab
- +3 more
- (no location specified)
Aug 16, 2023
Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)
Recruiting
- Esophageal Carcinoma
- Neoadjuvant Immunotherapy
- PD-1 blockade
- +2 more
-
Beijing, Beijing, ChinaQin li
Mar 8, 2023
Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)
Not yet recruiting
- Chemotherapy
- Radiation Therapy
- Camrelizumab
- +3 more
-
Fuzhou, ChinaFujian Medical University Union Hospital
Apr 6, 2023
EsophaCap for the Detection of Early Esophageal Carcinoma
Recruiting
- Barrett Esophagus
- +2 more
-
Baltimore, Maryland
- +1 more
Dec 8, 2022
Nivolumab in Treatment of Early Stage Esophageal or
Not yet recruiting
- Esophageal Carcinoma
- Gastroesophageal Junction Carcinoma
-
Louisville, Kentucky
- +2 more
Mar 21, 2023
Esophageal Carcinoma Trial in Nanjing (Nimotuzumab, Tigio, Concurrent radiation therapy)
Enrolling by invitation
- Esophageal Carcinoma
- Nimotuzumab
- +2 more
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023
Neoadjuvant Chemotherapy Compared With Surgery for Esophageal
Completed
- Esophagus Cancer
- Paclitaxel- and platinum-based chemotherapy
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 5, 2022
Esophageal Squamous Cell Carcinoma Trial in Nanjing, Shanghai (Radiotherapy)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Radiotherapy
-
Nanjing, Jiangsu, China
- +2 more
Jul 14, 2022
Minimally Residual of Esophageal Cancer 001
Recruiting
- Esophageal Carcinoma
- Minimal Residual Disease
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Jul 17, 2023
Esophageal Carcinoma Trial in Shijiazhuang (toripalimab)
Recruiting
- Esophageal Carcinoma
-
Shijiazhuang, Hebei, ChinaFourth Hospital of Hebei Medical University
Aug 20, 2023
Esophageal Carcinoma Trial in Tianjin (camrelizumab)
Recruiting
- Esophageal Carcinoma
-
Tianjin, ChinaTianjin Medical University Cancer Institute & Hospital
Jul 25, 2022
Squamous Cell Esophageal Carcinoma, Esophageal Cancer, Oesophageal Cancer Trial in Guangzhou (drug, radiation, procedure)
Recruiting
- Squamous Cell Esophageal Carcinoma
- +2 more
- Sintilimab
- +4 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 11, 2022
Local Advanced Esophageal Carcinoma
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai cancer center
Jun 16, 2022
Atrial Fibrillation, Esophageal Carcinoma Trial in Portland (Amiodarone Hydrochloride, Saline)
Not yet recruiting
- Atrial Fibrillation
- Esophageal Carcinoma
- Amiodarone Hydrochloride
- Saline
-
Portland, OregonOHSU Knight Cancer Institute
Sep 28, 2023
Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Tokyo (Nivolumab, 5-FU, CDDP)
Recruiting
- Locally Advanced Esophageal Squamous Cell Carcinoma
- Nivolumab
- +3 more
-
Tokyo, JapanNational Cancer Center Hospital
Apr 5, 2022
Esophageal Cancer Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence Endoscopy platform)
Recruiting
- Esophageal Cancer
- Bevacizumab-IRDye800CW
- Molecular Fluorescence Endoscopy platform
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 19, 2022
Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)
Recruiting
- Esophageal Cancer
- +3 more
- Neoadjuvant immunochemotherapy
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 2, 2022
Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1
Recruiting
- Metastatic Esophageal Squamous Cell Carcinoma
- TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors(Sintilimab)
-
Qingdao, Shandong, China
- +1 more
Nov 13, 2023
Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)
Recruiting
- Esophageal Squamous Cell Carcinoma
- no intervention
-
Wuhan, Hubei, ChinaRenmin hosptial of Wuhan University
Jul 29, 2023
Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with
Not yet recruiting
- Advanced Esophageal Squamous Carcinoma With Oligometastases
- simultaneous with radiotherapy
- synchronous with radiotherapy
- (no location specified)
Nov 16, 2023
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 30, 2023
Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shijiazhuang, Hebei, ChinaDepartment of Thoracic Surgery, Fourth Hospital of Hebei Medical
Oct 25, 2023